One Day, Three IRD Gene Therapy Triumphs
January 8, 2025, was no ordinary day in the world of gene therapy for inherited retinal diseases (IRDs)—it was a…
Rethinking Retinal Disease Treatment and Management with TOPCON Technology
From dry AMD to diabetic retinopathy and beyond, TOPCON is reimagining the future of retinal medicine with the TOPCON DRI…
latest posts
